Hyster-Yale stock faces a projected 2026 loss after Q2 red ink

Published on 10/06/2026 at 15:48 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Hyster-Yale stock carries a projected 2026 GAAP loss after Q2 EPS came in at USD 1.64 below zero on August 4, 2026. Revenue reached USD 812.90 million above consensus.

HY, US4491721050, Illustration mit AI erstellt.

Hyster-Yale (ISIN US4491721050) was trading at USD 32.05 on the NYSE on October 6, 2026, at 9:46 a.m. ET, up 0.34 percent from the prior close. The central issue for Hyster-Yale stock is a projected 2026 GAAP loss of USD 2.91 per share after the company reported a second-quarter loss. As MarketBeat reported on October 1, 2026, the latest quarter combined revenue above estimates with continuing losses.

Q2 revenue beat expectations

For Q2 2026, Hyster-Yale generated USD 812.90 million in revenue and reported GAAP EPS of USD 1.64 below zero. Revenue exceeded the USD 804.62 million consensus by USD 8.28 million, while the loss was narrower than the USD 2.20 per-share estimate, according to MarketBeat.

The finance picture remains uneven. Standardized Q2 data show consolidated net income of negative USD 31.3 million and an operating margin of negative 2.0 percent for the quarter ended June 30, 2026, while operating cash flow was positive at USD 16.7 million.

Forecasts point to another loss

For the September 2026 quarter, the average GAAP EPS estimate is a loss of USD 0.40, compared with a loss of USD 0.09 in the year-earlier quarter. The average revenue estimate is USD 926.45 million, down 5.38 percent from USD 979.10 million a year earlier, according to Yahoo Finance on October 6, 2026.

That forecast gives the stock a clear operating test: revenue would need to recover sequentially from USD 812.90 million, while the company would still be expected to post a quarterly loss. The contrast between a revenue beat and negative earnings keeps margin recovery central to the investment case.

Analysts see upside but mixed risk

MarketBeat reports a Hold consensus from four analysts and an average price target of USD 47.50. At USD 32.05, the price lies 32.5 percent below that target, while the published analyst ratings range from Sell to Buy.

Markets Insider separately reported on September 28, 2026, that Northland Securities analyst Ted Jackson maintained a Buy rating and a USD 55.00 target for Hyster-Yale, while the same report cited a Moderate Buy consensus and a USD 50.00 average target from TipRanks, showing that consensus measures differ by provider.

Makkler lists November 3, 2026, as the next reporting date, with an EPS estimate of negative USD 0.59 and revenue estimate of USD 926.45 million.

Stock stays below yearly high

Hyster-Yale stock was trading at USD 32.05 on the NYSE on October 6, 2026, with a session range of USD 32.05 to USD 32.36. The 52-week range is USD 26.41 to USD 41.30, and the company has a market capitalization of USD 570.2 million.